Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2

Area of Science:

• Infectious Diseases
• Pathophysiology
• Systemic Manifestations

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, emerged in December 2019.
• Initially recognized for pulmonary injury, COVID-19 is now understood as a systemic infection.
• The pandemic has become the most significant global health crisis in a century.

Purpose of the Study:

• To provide a comprehensive overview of non-pulmonary involvement in COVID-19.
• To elucidate the underlying pathophysiological mechanisms of systemic effects.
• To describe the clinical presentation of non-pulmonary manifestations.

Main Methods:

• Literature review of scientific articles and case reports.
• Analysis of studies focusing on organ systems affected by SARS-CoV-2.
• Synthesis of information on pathophysiology and clinical findings.

Main Results:

• SARS-CoV-2 affects multiple organs, including the heart, vascular endothelium, and CNS.
• Abnormalities in hemostasis, kidneys, and the gastrointestinal tract are observed.
• COVID-19 presents with diverse clinical manifestations, varying in severity and distribution.

Conclusions:

• COVID-19 is a systemic disease with widespread organ involvement.
• Non-pulmonary manifestations significantly impact disease course and prognosis.
• Understanding these systemic effects is crucial for managing COVID-19 patients.